Eric J Small Selected Research

Cancer Pain

10/2015	Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.
1/2013	Abiraterone in metastatic prostate cancer without previous chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric J Small Research Topics

Disease

250	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 02/2002
118	Neoplasms (Cancer) 03/2024 - 06/2002
46	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2002
33	Disease Progression 12/2023 - 08/2002
25	Leukemia 03/2024 - 08/2002
21	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 04/2004
14	Carcinoma (Carcinomatosis) 10/2023 - 12/2003
12	Adenocarcinoma 12/2022 - 08/2002
9	Pain (Aches) 12/2023 - 12/2003
9	Fatigue 12/2023 - 03/2005
6	Hypertension (High Blood Pressure) 01/2023 - 11/2008
6	Neutropenia 01/2022 - 12/2003
5	Exanthema (Rash) 01/2021 - 03/2007
4	Transitional Cell Carcinoma 10/2023 - 04/2003
4	Melanoma (Melanoma, Malignant) 12/2020 - 04/2013
3	Carcinogenesis 11/2022 - 01/2018
3	Proteinuria 01/2021 - 11/2008
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 07/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 09/2002
3	Margins of Excision 05/2008 - 08/2002
2	Lymphatic Metastasis 12/2022 - 05/2005
2	Febrile Neutropenia 01/2022 - 03/2005
2	Hypoxia (Hypoxemia) 07/2019 - 04/2004
2	Circulating Neoplastic Cells 12/2017 - 09/2017
2	Diarrhea 01/2017 - 09/2012

Drug/Important Bio-Agent (IBA)

83	AndrogensIBA 12/2023 - 02/2002
57	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 06/2002
54	Hormones (Hormone)IBA 01/2020 - 06/2002
32	Docetaxel (Taxotere)FDA Link 03/2024 - 12/2003
23	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 07/2003
23	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2004
22	AntigensIBA 03/2024 - 02/2002
21	sipuleucel-T (APC8015)FDA Link 01/2021 - 06/2005
20	Abiraterone AcetateIBA 01/2023 - 03/2010
19	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2002
17	apalutamideIBA 12/2023 - 01/2018
15	Bevacizumab (Avastin)FDA Link 03/2024 - 04/2004
14	enzalutamideIBA 01/2023 - 05/2015
11	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2016 - 01/2003
10	Testosterone (Sustanon)FDA Link 01/2022 - 08/2002
10	Estramustine FDA Link 02/2011 - 12/2003
9	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2017
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 04/2004
8	Gemcitabine FDA Link 10/2023 - 04/2003
8	abirateroneIBA 01/2023 - 01/2013
8	Ketoconazole (Nizoral)FDA LinkGeneric 12/2014 - 08/2002
7	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 04/2003
7	Tyrosine Kinase InhibitorsIBA 07/2019 - 09/2002
7	prostatic acid phosphataseIBA 08/2015 - 10/2003
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
6	IpilimumabIBA 01/2021 - 03/2007
6	cabozantinibIBA 11/2019 - 02/2013
6	gallium 68 PSMA-11IBA 06/2019 - 01/2017
6	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017 - 10/2004
5	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2012
5	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 07/2019
5	Phenobarbital (Luminal)FDA Link 11/2021 - 01/2019
5	taxaneIBA 01/2020 - 01/2006
5	Interferon-alpha (Interferon Alfa)IBA 01/2014 - 04/2004
5	ixabepilone (BMS 247550)FDA Link 06/2011 - 03/2005
5	ErbB Receptors (EGF Receptor)IBA 09/2009 - 09/2002
5	Gefitinib (Iressa)FDA Link 01/2008 - 09/2002
4	Cell-Free Nucleic AcidsIBA 11/2022 - 05/2015
4	Sunitinib (Sutent)FDA Link 11/2019 - 01/2017
4	Hemoglobins (Hemoglobin)IBA 10/2019 - 04/2013
4	AntibodiesIBA 01/2018 - 05/2006
4	Monoclonal AntibodiesIBA 04/2013 - 07/2004
4	Insulin-Like PeptidesIBA 07/2012 - 03/2007
4	Suramin (Suramin Sodium)IBA 06/2006 - 08/2002
4	Carboplatin (JM8)FDA LinkGeneric 10/2005 - 04/2003
4	herbal preparation PC-SPESIBA 09/2005 - 02/2002
4	Diphosphonates (Bisphosphonates)IBA 12/2003 - 05/2002
3	LigandsIBA 01/2023 - 03/2005
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
3	RadiopharmaceuticalsIBA 01/2023 - 12/2013
3	Alkaline PhosphataseIBA 10/2019 - 12/2003
3	VaccinesIBA 09/2015 - 07/2006
3	Estrogens (Estrogen)FDA Link 10/2009 - 05/2002
3	Cancer VaccinesIBA 05/2007 - 10/2003
3	Androgen Antagonists (Antiandrogens)IBA 04/2007 - 07/2003
3	thiamine triphosphorate (TTP)IBA 07/2006 - 07/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 06/2002
2	enfortumab vedotinIBA 10/2023 - 01/2023
2	hydrogen sulfite (bisulfite)IBA 01/2023 - 01/2020
2	antiarrhythmic peptide (AAP)IBA 01/2023 - 01/2023
2	Circulating Tumor DNAIBA 01/2020 - 12/2017
2	PlatinumIBA 01/2020 - 10/2005
2	Phosphotransferases (Kinase)IBA 12/2019 - 07/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2019 - 10/2007
2	bicalutamide (Casodex)FDA LinkGeneric 05/2019 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 01/2017
2	Dehydroepiandrosterone (DHEA)IBA 12/2017 - 10/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2017 - 02/2013

Therapy/Procedure

130	Therapeutics 12/2023 - 02/2002
126	Castration 03/2024 - 08/2002
48	Drug Therapy (Chemotherapy) 10/2023 - 09/2004
34	Immunotherapy 01/2023 - 06/2003
15	Radiotherapy 01/2023 - 06/2002
15	Prostatectomy (Retropubic Prostatectomy) 08/2021 - 06/2002
8	Aftercare (After-Treatment) 11/2021 - 11/2004